Literature DB >> 33652919

Protective Effect of Tuna Bioactive Peptide on Dextran Sulfate Sodium-Induced Colitis in Mice.

Xing-Wei Xiang1,2, Xiao-Ling Zhou3, Rui Wang1, Cong-Han Shu3, Yu-Fang Zhou4, Xiao-Guo Ying3, Bin Zheng3.   

Abstract

Bioactive peptides isolated from marine organisms have shown to have potential anti-inflammatory effects. This study aimed to investigate the intestinal protection effect of low molecular peptides (Mw < 1 kDa) produced through enzymatic hydrolysis of tuna processing waste (tuna bioactive peptides (TBP)) on dextran sulfate sodium (DSS)-induced ulcerative colitis (UC) in BALB/c mice. Here, we randomly divided twenty-four male BALB/c mice into four groups: (i) normal (untreated), (ii) DSS-induced model colitis, (iii) low dose TBP+DSS-treated (200 mg/kg/d), and (iv) high dose TBP+DSS-treated groups (500 mg/kg/d). The results showed that TBP significantly reduced mice weight loss and improved morphological and pathological characteristics of colon tissues. In addition, it increased the activities of antioxidant enzymes (SOD and GSH-Px) and decreased inflammatory factors (LPS, IL-6, and TNF-α) expression. TBP increased the gene expression levels of some tight junction (TJ) proteins. Moreover, TBP increased the short-chain fatty acids (SCFAs) levels and the diversity and imbalance of intestinal flora. Therefore, TBP plays some protective roles in the intestinal tract by enhancing antioxidant and anti-inflammatory abilities of the body, improving the intestinal barrier and metabolic abnormalities, and adjusting intestinal flora imbalance.

Entities:  

Keywords:  inflammation; intestinal barrier; intestinal flora; low molecular weight peptides; short-chain fatty acid; ulcerative colitis

Mesh:

Substances:

Year:  2021        PMID: 33652919      PMCID: PMC7996728          DOI: 10.3390/md19030127

Source DB:  PubMed          Journal:  Mar Drugs        ISSN: 1660-3397            Impact factor:   5.118


  42 in total

1.  Valorisation of tuna processing waste biomass: isolation, purification and characterisation of four novel antioxidant peptides from tuna by-product hydrolysate.

Authors:  Sami Saidi; Mongi Saoudi; Raja Ben Amar
Journal:  Environ Sci Pollut Res Int       Date:  2018-04-13       Impact factor: 4.223

2.  Dietary supplementation of aspartate enhances intestinal integrity and energy status in weanling piglets after lipopolysaccharide challenge.

Authors:  Dingan Pi; Yulan Liu; Haifeng Shi; Shuang Li; Jack Odle; Xi Lin; Huiling Zhu; Feng Chen; Yongqing Hou; Weibo Leng
Journal:  J Nutr Biochem       Date:  2014-01-16       Impact factor: 6.048

Review 3.  Small Bioactive Peptides for Biomaterials Design and Therapeutics.

Authors:  I W Hamley
Journal:  Chem Rev       Date:  2017-12-11       Impact factor: 60.622

Review 4.  Intestinal barrier and gut microbiota: Shaping our immune responses throughout life.

Authors:  Tatiana Takiishi; Camila Ideli Morales Fenero; Niels Olsen Saraiva Câmara
Journal:  Tissue Barriers       Date:  2017-09-28

5.  Effects of IRW and IQW on Oxidative Stress and Gut Microbiota in Dextran Sodium Sulfate-Induced Colitis.

Authors:  Gang Liu; Wenxin Yan; Sujuan Ding; Hongmei Jiang; Yong Ma; Hua Wang; Jun Fang
Journal:  Cell Physiol Biochem       Date:  2018-11-19

6.  Purification and characterization of a novel peptide with inhibitory effects on colitis induced mice by dextran sulfate sodium from enzymatic hydrolysates of Crassostrea gigas.

Authors:  Jin-Woo Hwang; Seung-Jae Lee; Yon-Suk Kim; Eun-Kyung Kim; Chang-Bum Ahn; You-Jin Jeon; Sang-Ho Moon; Byong-Tae Jeon; Pyo-Jam Park
Journal:  Fish Shellfish Immunol       Date:  2012-08-30       Impact factor: 4.581

7.  An orally administered butyrate-releasing xylan derivative reduces inflammation in dextran sulphate sodium-induced murine colitis.

Authors:  Zhengqi Zha; Yang Lv; Huiling Tang; Tingting Li; Yinghua Miao; Junwei Cheng; Guoqing Wang; Yanfang Tan; Yan Zhu; Xiao Xing; Kang Ding; Ying Wang; Hongping Yin
Journal:  Int J Biol Macromol       Date:  2019-11-21       Impact factor: 6.953

Review 8.  Microbiota dysbiosis and barrier dysfunction in inflammatory bowel disease and colorectal cancers: exploring a common ground hypothesis.

Authors:  Linda Chia-Hui Yu
Journal:  J Biomed Sci       Date:  2018-11-09       Impact factor: 8.410

9.  Microbiology: Wealth management in the gut.

Authors:  Sungsoon Fang; Ronald M Evans
Journal:  Nature       Date:  2013-08-29       Impact factor: 49.962

Review 10.  The gut microbiota and host health: a new clinical frontier.

Authors:  Julian R Marchesi; David H Adams; Francesca Fava; Gerben D A Hermes; Gideon M Hirschfield; Georgina Hold; Mohammed Nabil Quraishi; James Kinross; Hauke Smidt; Kieran M Tuohy; Linda V Thomas; Erwin G Zoetendal; Ailsa Hart
Journal:  Gut       Date:  2015-09-02       Impact factor: 23.059

View more
  4 in total

1.  Oyster (Crassostrea gigas) Extract Attenuates Dextran Sulfate Sodium-Induced Acute Experimental Colitis by Improving Gut Microbiota and Short-Chain Fatty Acids Compositions in Mice.

Authors:  Tatsuya Ishida; Hiroyuki Matsui; Yoshikazu Matsuda; Ryota Hosomi; Takaki Shimono; Seiji Kanda; Toshimasa Nishiyama; Kenji Fukunaga; Munehiro Yoshida
Journal:  Foods       Date:  2022-01-27

2.  Tilapia skin peptides, a by-product of fish processing, ameliorate DSS-induced colitis by regulating inflammation and inhibiting apoptosis.

Authors:  Jiahui Gao; Lixiang Li; Dong Zhao; Xia Wang; Yanan Xia; Bing Li; Chang Liu; Xiuli Zuo
Journal:  Front Nutr       Date:  2022-09-08

Review 3.  Fish and Shellfish-Derived Anti-Inflammatory Protein Products: Properties and Mechanisms.

Authors:  David C Kemp; Jung Yeon Kwon
Journal:  Molecules       Date:  2021-05-27       Impact factor: 4.411

4.  Fish Sidestream-Derived Protein Hydrolysates Suppress DSS-Induced Colitis by Modulating Intestinal Inflammation in Mice.

Authors:  Maria G Daskalaki; Konstantinos Axarlis; Tone Aspevik; Michail Orfanakis; Ourania Kolliniati; Ioanna Lapi; Maria Tzardi; Eirini Dermitzaki; Maria Venihaki; Katerina Kousoulaki; Christos Tsatsanis
Journal:  Mar Drugs       Date:  2021-05-28       Impact factor: 5.118

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.